Mary Newman, SVP, Regulatory Affairs at Audentes Therapeutics, Inc. (BOLD), sold 10,000 shares at $20.00 ($200K) on 2017-08-24, disclosed to the SEC on 2017-08-25.
Open-market sale of $200k BOLD by SVP, Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BOLD | SELL | 2017-11-17 | $537K | — | Filing → |